<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>There has been accumulating evidence that chemokines play an important role in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Chemokines-like factor 1 (CKLF1), as a novel C-C chemokine, is upregulated in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In this study we examined the protective effect of C19, a C-terminal <z:chebi fb="7" ids="16670">peptide</z:chebi> of chemokine-like factor 1, in an animal model of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Adult rats were anesthetized with chloral <z:chebi fb="1" ids="35505">hydrate</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>C19 was given intracerebroventricularly immediately after 60 min middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Animals were examined for their neurological function, <z:mpath ids='MPATH_124'>infarct</z:mpath> size and water content at 24h after reperfusion </plain></SENT>
<SENT sid="6" pm="."><plain>The result showed that C19 (0.1, 1, 10 or 50 μg) significantly improved neurological function, decreased <z:mpath ids='MPATH_124'>infarct</z:mpath> size and water content in a dose-dependent manner </plain></SENT>
<SENT sid="7" pm="."><plain>In contrast, application of C19 (50 μg) showed no effect in <z:mpath ids='MPATH_458'>normal</z:mpath> rats </plain></SENT>
<SENT sid="8" pm="."><plain>Taken together, our data suggest that C19 is protective against ischemic brain injury, and may be an ideal <z:chebi fb="7" ids="16670">peptide</z:chebi> drug for the treatment of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
</text></document>